TCL Archive Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes February 5, 1982
TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010